◆ SpookStack

i FD-302a (Rev. 10-6-95) e @ 279A-WE-222936-USAMRIID — . ; bTe Continuation of FD-302 of fm 02/06/2008 _,Page__2 to[__] knowledge researchers at USAMRIID never worked with dry spores just wet spore preparations of Bacillus anthracis. recalled that back in the September 11, 2001, time frame, both before and after the attacks, researchers in Division were still conducting recombinant Protein Antigen (rPA) anthrax vaccine research. explained that even oday, it was 1e is objective has not really Changed {__] advised the] never saw any kind of substantial decrease in funding for anthrax related research. While[_|was[___] LT the momentum for anthrax research was constant. was not aware of any significant concerns that IVINS may have had or voiced regarding the notion that anthrax research and/or specifically rPA possanctyes going away prior to the September 11, 2001 time frame re-iterated that IVINS's funding in the period of time preceding the anthrax-laced letter mailings o£ 2001 was stable and IVINS should not have been concerned[_—sopiined that maybe IVINS had assumed tha no longer going to be able to conduct anthrax research at. can not be sure of what IVINS was thinking at the time. advised that "[IVINS] would often make assumptions that were not necessarily true."[__| again reiterated could not be certain of what IVINS was thinking in the period of time leading up to the anthrax-laced letter mailings of 2001. also recalled that prior to the September 11, 2001 time frame IVINS was USAMRIID's technical representative to DUGWAY PROVING GROUNDS (DPG) pertaining to a project whereby DPG was contracted out to produce large quantities of wet Bacillus anthracis spores. Part of IVINS research responsibilities was to ensure or develop a standardized spore preparation system to be used in animal challenges and the DPG spores were to be used towards this goal. As an aside, [—_ ] recalled the DPG spores